Hot Features
Premium
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Deckers Outdoor Corp. (NASDAQ:DECK): The stock is up on the news of rating upgrade from Sterne Agee. Deckers Outdoor stock traded in the range of $41.51 and $42.55 in its current session and now is at $41.61, up 8.67 percent from its previous close. It is trading at beta of 0.8 and the stock’s Price Earnings ratio is 10.30. Sterne Agee upgraded the stock due to improvement in its brand positioning.
The company is also expected to improve its margins in second quarter. The stock has been given the price target of $65 and its new rating is Buy, up from Neutral. However, on the other hand, Deckers Outdoor saw Tiger Global, a major hedge fund, reducing its stake in the company. Deckers Outdoor designs, manufactures and markets various accessories including footwear for outdoor activities. The company offers its products under various brand names such as UGG and Mozo. It was formed in 1973 and is based out of California.
Dell Inc. (NASDAQ:DELL): The stock is trading 7.14 percent up from its previous close and is currently at $10.33. It has traded in the range of $8.69 and $18.36 in the past 52 weeks. Dell Inc. stock has been upgraded to Buy by Goldman Sachs. Its earlier rating was at Sell. Goldman Sachs reasons that the stock’s 31 percent value decline since December, 2010 makes Dell an attractive Buy at the current price point. Dell offers 3.3 percent dividend yield and its Price Earnings ratio is at 7.02. The company is an integrated technology solution provides and serves information technology industry. Dell provides its services to individual and corporate clients. It is based out of Round Rock in Texas and it was formed in 1984. Dell reported its latest Earnings per share at $1.47. Goldman Sachs set the price target for the stock at $13, up from its previous price target of $9. Goldman Sachs is also of the view that the company may experience leveraged buy out. The company currently has healthy cash reserve of $11 billion, as on November 2, 2012.
Equifax Inc. (NYSE:EFX): The stock hits its new 52 weeks high at $55.52 in its current trading session. Equifax is up on the news of its purchase of CSC Credit Unit. The transaction is expected to be worth $1 billion. Both the companies are looking to conclude the transaction by the end of this year. CSC will use the proceeds to fund its pension plan. Equifax will gain access to the unit’s credit files in 15 states. Equifax expects the Credit Unit to generate annual revenue in the range of $115 million and $125 million. The company stock touched its lowest price point in 52 weeks at $36.81. Equifax has beta of 0.89 and it is trading at Price Earnings ratio of 21.95. Its latest Earnings per Share stood at $2.44. Equifax offers information solutions to consumers and businesses. It collects and organizes information for analysis purpose. Equifax also provides credit information. The company is based out of Georgia and it was formed in 1989. It is operational in various countries including the US, Spain and Canada.
Globus Medical Inc. (NYSE:GMED): The company reported its third quarter revenue at $94.8 million, up 12.5 percent from its revenue for the corresponding quarter of the last year. However, the stock did not respond well to the announcement and is trading at $12.01, down 9.77 percent from its previous close. The stock traded in the range of $13.06 and $19.93 in the past 52 weeks while its range in current session stands at $11.75 and $13.34. Globus Medical reported its Non-GAAP adjusted EBITDA at 35.1 percent of its sales while its net income for the third quarter stood at $16.5 million. On per share basis, the net income was reported at 18 cents. The company derives its revenue from 23 countries across the globe and 8 percent of its revenue is derived from overseas. Globus Medical is a medical device outfit and it designs and markets various devices. The company specializes in developing devices for spinal disorders. It has more than 100 products in its portfolio. Globus Medical has market capitalization of $1.44 billion and its stock is trading at the Price Earnings ratio of 20.38.
